– Neil Patel, PharmD., Director of Pharmaceutical R&D Operations, PricewaterhouseCoopers

Previous articleResearchers Find Genetic Clues to HIV Resistance
Next articleCalibrant and Armed Forces Institute of Pathology Ally to Discover and Develop Protein Biomarkers